全部

1·The presence of protein was measured by western blotting.

蛋白的测定采用蛋白质印迹法。

2·Western blotting was used to detect protein expression of VEGF.

用免疫蛋白印迹法检测细胞VEGF蛋白表达。

3·Immunocytochemistry and western blotting technology were used to identify the cell phenotype.

用蛋白质印迹免疫检测技术和免疫细胞化学技术鉴定细胞表型。

4·The changes of BMP2 and osteopontin were detected by immunohistochemistry and Western blotting.

骨形态发生蛋白2与骨桥蛋白检测：采用免疫组织化学染色与蛋白印迹方法。

5·This product has been optimized for use as a secondary antibody in Western blotting applications.

该抗体已经过优化，可以作为二抗用于western blot实验。

6·Methods Immunohistochemical technique, image analysis, radioimmunoassay and Western blotting were used.

方法采用免疫组织化学技术、图像分析、放射免疫和免疫印迹法。

7·Objective: To determine the optimum experiment condition of detecting P—glycoprotein with Western blotting.

目的：确定蛋白免疫印迹检测大鼠脑组织中P-糖蛋白的最佳实验条件。

8·The viral NP and F proteins revealed the same patterns by Western Blotting with specific monoclonal antibodies.

二者的结构多肽NP蛋白和F蛋白用特异性单克隆抗体免疫转印技术分析，未显示差异。

9·Results: Stable expression of AIRE was confirmed by fluorescence microscope, FACS and western blotting analysis.

结果：经荧光显微镜、流式细胞仪及免疫印迹法检测，证实AIRE基因得到了稳定表达。

10·Western blotting also revealed an increase in HO-1 protein levels(P<0.01) but no change in HSP70 protein expression.

蛋白印迹也显示HO-1蛋白水平增加（P<0.01），但HSP70蛋白表达无明显变化。